Ignyte Acquisition Corp.
Completed
Follow
Detailed Information
Information on this SPAC.
- Sponsors
- IPO Size
- $50M
- Underwriters
- Focus
- Life Sciences, Biotech, Healthcare
- SEC Filings
- 1834645
- Public Embarc Page
- https://embarc.com/capital/spac/1834645/IGNY/ignyte-acquisition
- IPO Ticker
- IGNY
SPAC Leadership
Information on the SPAC leadership.
- Chairman of the Board and Co-Chief Executive OfficerDavid I. Rosenberg
- Co-Chief Executive Officer and DirectorDavid J. Strupp, Jr.
- Chief Financial OfficerSteven N. Kaplan
- DirectorCheryl L. Cohen
- DirectorCharles (“Chuck”) Wilson, Ph.D.
- DirectorJohn Andrew Boockvar, M.D.
- DirectorRichard J. Rosenstock
- David Rosenberg(Co-CEO, Ladenburg Thalmann)
- Chief Financial Officer and DirectorSteven Kaplan
- DirectorCheryl Cohen
- DirectorCharles Wilson, Ph.D.